Healthcare deductible costs rose at 16x the rate of inflation since 2006/ NYT
By The New York Times
Deductibles Rise Even Faster
By The New York Times
Pharmaceutical companies conduct pre-clinical (without people) and clinical research (utilizing human subjects) to understand the effects of drugs they are developing. Until now, even though the research often involves human voluntary subjects who may not be compensated for their participation, the findings of the research have been considered proprietary, or owned by the research sponsor….
SUN EDITORIAL: Overcoming Anthrax Doubts: Panel that will review government investigation of attacks must be independent (September 20, 2008) The FBI, the U.S. attorney for Washington, D.C., and postal inspectors did not convince everyone last month when they laid out their case against the late Army microbiologist Dr. Bruce Ivins. Ivins, they said with surety,…
Tess Lawrie’s group’s metaanalysis of ivermectin research papers, published in June, has received a great deal of positive attention. It was, as expected, carefully done. The authors graded the quality of the papers they reviewed. The abstract noted: “Therapeutic Advances: Meta-analysis of 15 trials found that ivermectin reduced risk of death compared with no…
CQ TODAY ONLINE NEWS Sept. 5, 2008 By Seth Stern, CQ Staff Members of the House Judiciary Committee made clear Friday they expect more answers from the FBI about its August announcement that a government scientist was responsible for the 2001 anthrax attacks on Capitol Hill and elsewhere. Committee members submitted a list of questions…
And in the US, the vaccine has not had any human testing yet. Moderna began injections last week but their study won’t complete till year’s end. By then the 512 people in the Moderna trial will be irrelevant to the tens of millions that already received this new booster, which so far has only completed…
12/01/21 A U.S. Food and Drug Administration advisory panel on Tuesday voted narrowly to recommend Emergency Use Authorization of Merck’s five-day pill to treat COVID, despite the panel expressing a host of concerns about the drug’s safety and efficacy. By Seth HancockLink copied https://childrenshealthdefense.org/defender/fda-vote-lagevrio-merck-covid-treatment-pill/ The U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee…